Dalrada Financial Corp
OTC:DFCO
Dalrada Financial Corp
Research & Development
Dalrada Financial Corp
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Dalrada Financial Corp
OTC:DFCO
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Research & Development
-$74.3m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-8%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Research & Development
-$1.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
|
Zimmer Biomet Holdings Inc
NYSE:ZBH
|
Research & Development
-$441.5m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
|
Insulet Corp
NASDAQ:PODD
|
Research & Development
-$270.8m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-22%
|
|
|
Dexcom Inc
NASDAQ:DXCM
|
Research & Development
-$590.4m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-16%
|
|
Dalrada Financial Corp
Glance View
Dalrada Financial Corp delivers next-generation manufacturing, engineering, healthcare products and services. The company is headquartered in Escondido, California. The firm operates in Malaysia, India, United Kingdom, and the United States of America. The Company’s operating subsidiaries include Dalrada Precision, Dalrada Health Products and Dalrada Technologies. The Company’s subsidiaries provide service to clean energy industry, healthcare industry and technology industry. The firm markets 10 products and services. The firm operates through five segments: Engineering, Health, Information Technology, Education and Corporate.